IP Verse

Recombinant Gallid Herpesvirus 3 (Mdv Serotype 2) Vectors Expressing Antigens Of Avian Pathogens And Uses Thereof - EP2785374

The patent EP2785374 was granted to Boehringer Ingelheim Animal Health USA on Aug 17, 2022. The application was originally filed on Nov 29, 2012 under application number EP12805843A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2785374

BOEHRINGER INGELHEIM ANIMAL HEALTH USA
Application Number
EP12805843A
Filing Date
Nov 29, 2012
Status
Patent Maintained As Amended
Jul 15, 2022
Grant Date
Aug 17, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

INTERVETSep 30, 2019INTERVET -

Patent Citations (25) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONEP0517292
DESCRIPTIONEP0719864
DESCRIPTIONUS4603112
DESCRIPTIONUS4708871
DESCRIPTIONUS4722848
DESCRIPTIONUS4769330
DESCRIPTIONUS5174993
DESCRIPTIONUS5187087
DESCRIPTIONUS5756103
DESCRIPTIONUS5853733
DESCRIPTIONUS5980906
DESCRIPTIONUS5980912
DESCRIPTIONUS6183753
DESCRIPTIONUS6719979
DESCRIPTIONWO8704463
DESCRIPTIONWO9816247
INTERNATIONAL-SEARCH-REPORTEP1298139
INTERNATIONAL-SEARCH-REPORTUS5980906
OPPOSITIONEP0334530
OPPOSITIONEP1298139
OPPOSITIONEP2785374
OPPOSITIONKR20010095727
OPPOSITIONUS5676952
OPPOSITIONUS5980906
OPPOSITIONWO2013082317

Non-Patent Literature (NPL) Citations (4) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
OPPOSITION- "glycoprotein C [Gallid alphaherpesvirus 3]", Protein, (20110620), Database accession no. AEI00252.1, XP055647360
OPPOSITION- SLACUM et al., "The compatibility of HVT recombinants with other Marek's disease vaccines", Proceedings of the 58th Western Poultry Disease Conference, Sacramento , CA , USA, (20090000), page 84, XP009167868
OPPOSITION- HIRAI et al., "REPLICATING MAREK'S DISEASE VIRUS (MDV) SEROTYPE 2 DNA WITH INSERTED MDV SEROTYPE 1 DNA SEQUENCES IN A MAREK'S DISEASE LYMPHOBLASTOID CELL LINE MSB1-41C", Archives of Virology, (19900000), vol. 114, pages 153 - 165, XP000654933
OPPOSITION- JANG et al., "The genetic organization and transcriptional analysis of the short unique region in the genome of nononcogenic Marek's disease virus serotype 2", Virus Research, (19980000), vol. 58, pages 137 - 147, XP055647424

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents